cuaj lꢀꢁꢁꢀrtes  
xt  
CUAJ Letters is an open forum to  
discuss papers published in CUAJ.  
The neutrophil-to-lymphocyte ratio in  
clinical practice  
Letters are published at the discretion  
of the editors, and are subject to  
abridgement and editing for style and  
content. Letters can be sent to the  
Editor at journal@cua.org.  
1
2
Ali Gürağ  
aç, MD; Zafer Demirer, MD  
1
2
Tatvan Military Hospital, Department of Urology, Bitlis, Turkey; Eskisehir Military Hospital, Department of Urology, Eskisehir, Turkey  
Cite as: Can Urol Assoc J 2016;10(3-4):141-2. http://dx.doi.  
org/10.5489/cuaj.3587  
trophils and lymphocytes are thought  
to be significant in tumour immunol-  
ogy and inflammation. Inflammation  
References  
1
.
Gokce MI, Hamidi N, Suer E, et al. Evaluation of neutrophil-to-  
lymphocyte ratio prior to prostate biopsy to predict biopsy histo-  
logy: Results of 1836 patients. Can Urol Assoc J 2015;9:E761-5.  
http://dx.doi.org/10.5489/cuaj.3091  
e read with great interest  
the article, “Evaluation of  
neutrophil-to-lymphocyte  
plays a significant role in the prolife-  
ration, angiogenesis, and metastasis  
of cancer cells and is important in  
the development and progression of  
W
2
.
Zahorec R. Ratio of neutrophil to lymphocyte counts—rapid and  
simple parameter of systemic inflammation and stress in critically  
ill. Bratisl LekListy 2001;102:5-14.  
ratio prior to prostate biopsy to pre-  
dict biopsy histology: Results of 1836  
2
,3  
the disease. Even when white blood  
cell count is in normal range, NLR has  
been demonstrated to play a predictive  
role in the prognosis of chronic and  
1
3. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and  
cancer. Cell 2010;140:883-99. http://dx.doi.org/10.1016/j.  
cell.2010.01.025  
patients,” by Gokce et al. Investigators  
aimed to evaluate the role of neutrop-  
hil-to-lymphocyte ratio (NLR) prior to  
prostate biopsy to predict biopsy his-  
tology and Gleason score in patients  
with prostate cancer.  
4
.
Ozcan C, Telli O, Ozturk E, et al. The prognostic significance of  
preoperative leukocytosis and neutrophil-to-lymphocyte ratio in  
patients who underwent radical cystectomy for bladder cancer. Can  
Urol Assoc J 2015;9:E789-94. http://dx.doi.org/10.5489/  
cuaj.3061  
2
-12  
acute inflammatory processes.  
A recent meta-analysis study conc-  
ludes that a high NLR is an independent  
factor associated with poorer overall  
survival in many solid tumours (colore-  
ctal, hepatocellular, gastroesophageal,  
ovarian, and pancreatic carcinoma).  
This marker may be associated with  
renal or hepatic dysfunction, diabetes  
mellitus, abnormal thyroid function,  
hypertension, metabolic syndrom,  
hematological malignancies, known  
malignancy, preceding history of local  
or systemic infection, inflammatory  
diseases, and any use of medication  
connected to inflammatory status of  
The mean NLR of the prostate can-  
cer group was significantly higher than  
that of the benign prostatic hypertrop-  
hy (BPH) group (p=0.002). The mean  
NLR of the prostatitis group was higher  
than that of both the prostate cancer  
and BPH groups (p=0.0001). The mean  
NLR of the Gleason score (GS) 8–10  
group was higher than that of the GS 7  
and GS 56 groups. The authors conc-  
lude that NLR was found to vary with  
regard to histology of prostate biopsy  
and higher GS was associated with  
higher NLR in patients with prostate  
cancer.  
5
6
.
.
Maeda Y, Kawahara T, Kumano Y, et al. The neutrophil-to-lymp-  
hocyte ratio before repeat prostate needle biopsy for predicting  
prostate cancer. Urol Int 2015 Dec 16. [Epub ahead of print].  
http://dx.doi.org/10.1159/000442895  
Kaynar M, Yıldırım ME, Badem H, et al. Bladder cancer invasion  
predictability based on preoperative neutrophil–lymphocyte ratio.  
Tumour Biol 2014;35:6601-5. http://dx.doi.org/10.1007/  
s13277-014-1889-x  
7. Demirer Z, Uslu AU. More work needed in examining the relations-  
hip between mean platelet volume and inflammation in varicocele  
pathophysiology. Can Urol Assoc J 2015;9:E639. http://dx.doi.  
org/10.5489/cuaj.3114  
8
.
Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role  
of neutrophil-to-lymphocyte ratio in solid tumours: A systematic  
review and meta-analysis. J Natl Cancer Inst 2014;106:dju124.  
http://dx.doi.org/10.1093/jnci/dju124  
9
-12  
patients.  
The authors should have  
9
.
Balta S, Demirer Z, Aparci M, et al. The relation between lymp-  
hocyte-monocyte ratio and renal cell carcinoma. Urol Oncol  
mentioned these factors.  
Complete blood count is a inex-  
pensive, comparatively routine, and  
practical laboratory test that gives  
us important information about the  
patient’s formed blood contents.  
Routine peripheral blood counts may  
be useful in diagnosis and prognosis  
of many disorders, including prostatic  
diseases.2  
In conclusion, we strongly believe  
the findings obtained from the current  
study will lead to further studies exa-  
mining the evaluation of NLR prior to  
prostate biopsy to predict biopsy his-  
tology.  
2
015;33:421.  
1
1
1
0. Demirer Z, Uslu AU. Predictive value of neutrophil-lymphocyte ratio  
in non-muscle-invasive bladder cancer. Urol Oncol 2016;34:1-2.  
http://dx.doi.org/10.1016/j.urolonc.2015.09.006  
1. Balta S, Demırer Z, Aparci M, et al. The lymphocyte-monocyte  
ratio in clinical practice. J Clin Pathol 2016;69:88-9. http://  
dx.doi.org/10.1136/jclinpath-2015-203233  
2. Demirer Z, Uslu AU, Balta S. Letter to the editor: Predictive value  
of the neutrophil-lymphocyte ratio and mean platelet volume in  
testicular torsion. Korean J Urol 2015;56:601-2.  
Competıng ınterests: The authors declare no competing financial  
or personal interests.  
-12  
NLR is measured by dividing the  
number of neutrophils by the number  
of lymphocytes. NLR may be an indi-  
cator of systemic inflammation, as neu-  
Correspondence: Dr. Zafer Demirer, Eskisehir Military Hospital,  
Department of Urology, Eskisehir, Turkey; zaferdemirer@mynet.com  
CUAJ • March-April 2016 • Volume 10, Issues 3-4  
141  
cuaj letteꢂꢃ  
especially important for use in devel-  
oping countries.  
and immune response to development  
and progression of prostate cancer  
cells. A study with immunohistochemi-  
cal examination of the prostate tissue  
from biopsy or radical prostatectomy  
specimens would better identify the  
changes in the prostatic tissue level.  
Author reply:  
Distinct phases of carcinogenesis  
and cancer growth cause different  
The neutrophil-to-  
lymphocyte ratio in  
clinical practice  
5
immune system responses. Initially,  
association of NLR and prostate can-  
cer was shown in metastatic cases,  
that is, higher NLR indicated more  
aggressive disease and poor response  
Competing interests: The authors declare no competing financial  
or personal interests.  
6
to treatment. Recently, further stud-  
1
Mehmet Ilker Gokce, MD;  
ies investigating the role of NLR in the  
1
1,7  
Nurullah Hamidi, MD;  
pre-biopsy setting were published. In  
1
these studies, higher NLR values were  
found to be associated with higher  
rates of prostate cancer. There is also  
one study focusing on and early-stage  
and low-risk prostate cancer. In this  
study, Kwon et al found that lym -  
phocyte count was associated with  
Gleason score upgrading and neutro-  
phil count was associated with bio-  
chemical failure; NLR was not found to  
have association with any of the study  
References  
Evren Suer, MD;  
Semih Tangal, MD;2  
Adil Huseynov, MD;  
1
.
Gokce MI, Hamidi N, Suer E, et al. Evaluation of neutrophil-to-  
lymphocyte ratio prior to prostate biopsy to predict biopsy histol-  
ogy: Results of 1836 patients. Can Urol Assoc J 2015;9:E761-5.  
http://dx.doi.org/10.5489/cuaj.3091  
1
1
Arif Ibiş, MD  
2
3
.
.
Cary KC, Cooperberg MR. Biomarkers in prostate cancer surveillance  
and screening: Past, present, and future.Ther Adv Urol 2013;5:318-  
1
Department of Urology, Ankara University School of Medicine,  
2
Ankara, Turkey; Department of Urology, Ufuk University School  
2
9. http://dx.doi.org/10.1177/1756287213495915  
Catalona WJ, Partin AW, Sanda MG, et al. A multicenterstudy of  
-2]pro-prostate-specific antigen combined with prostate-specific  
of Medicine, Ankara, Turkey  
[
antigen and free prostate-specific antigen for prostate cancer detec-  
tion in the 2.0 to 10.0 ng/ml prostate-specific antigen range.  
J Urol 2011;185:1650-5. http://dx.doi.org/10.1016/j.  
juro.2010.12.032  
Cite as: Can Urol Assoc J 2016;10(3-4):141-2. http://dx.doi.  
org/10.5489/cuaj.3630  
8
endpoints.  
Our group also investigated the  
results of low-risk cases in which the  
patients underwent radical prostatec-  
tomy. We found that NLR was asso-  
ciated with higher rates of Gleason  
score upgrading and high-grade pros-  
tate cancer cases, but not with disease  
upstaging (data not yet published).  
Although the results from the ear-  
ly-stage prostate cancer cases are  
conflicting, there is good proof of  
alterations in the immune system in  
the development and progression of  
prostate cancer. However, as it was  
mentioned in the comment to our  
study, levels of immune cells in the  
peripheral blood are prone to change  
4
5
6
.
.
.
Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate  
cancer: Prediction, detection, and monitoring. Nat Rev Cancer  
e would like to thank our  
2
008;8:268-78. http://dx.doi.org/10.1038/nrc2351  
colleagues for their precise  
Kim R, Emi M, Tanabe K. Cancer immunoediting from immune  
surveillance to immune escape. Immunology 2007;121:1-14.  
http://dx.doi.org/10.1111/j.1365-2567.2007.02587.x  
van Soest RJ, Templeton AJ, Vera-Badillo FE, et al. Neutrophil-  
to-lymphocyte ratio as a prognostic biomarker for men with  
metastatic castration-resistant prostate cancer receiving first-line  
chemotherapy: Data from two randomized phase 3 trials. Ann  
Oncol 2015; 26:743-9. http://dx.doi.org/10.1093/annonc/  
mdu569  
Kawahara T, Fukui S, Sakamaki K, et al. Neutrophil-to-lymphocyte  
ratio predicts prostatic carcinoma in men undergoing needle  
biopsy. Oncotarget 2015;6:32169-76.  
Kwon YS, Han CS, Yu JW, et al. Neutrophil and lymphocyte counts  
as clinical markers for stratifying low-risk prostate cancer. Clin  
Genitourin Cancer 2016;14:e1-8. http://dx.doi.org/10.1016/j.  
clgc.2015.07.018  
1
W
comments on our article.  
Neutrophil-to-lymphocyte ratio (NLR)  
is a valuable tool for evaluation of  
inflammation and is obtained from  
an inexpensive and widely attainable  
laboratory test — complete blood  
count. Currently, there are valuable  
tests for prediction of prostate cancer,  
particularly high-grade cases. These  
tests include: PCA3; prostate health  
index (PHI) multibiomarker test, which  
combines free and total prostate-spe-  
cific antigen (PSA) with [-2]proPSA;  
and four kallikrein protein biomarkers  
7
8
.
.
9
.
Balta S, Demırer Z, Aparci M, et al. The lymphocyte-monocyte ratio  
in clinical practice. J ClinPathol 2016;69:88-9. http://dx.doi.  
org/10.1136/jclinpath-2015-203233  
9
in many circumstances. Due to the  
(
total PSA, free PSA, intact PSA, and  
retrospective nature of our study, we  
could not retrieve data on the condi-  
tions that might have affected levels of  
immune cells. On the other hand, such  
data, although valuable, still does not  
clarify the changes in immune system  
human kallikrein-related peptidase 2),  
2
-4  
named as 4K score. However, these  
tests are expensive and not yet avail-  
able worldwide. Therefore, tests that  
are widely available, like NLR, are  
Correspondence: Dr. Mehmet Gokce, Department of Urology,  
Ankara University School of Medicine, Ankara, Turkey;  
migokce@yahoo.com  
1
42  
CUAJ • March-April 2016 • Volume 10, Issues 3-4